Omnicell, a leader in transforming pharmacy and nursing care delivery, has appointed Perry A. Genova, PhD, as Senior Vice President and Chief Technology Officer. Dr. Genova will lead the company’s technology strategy to address issues in medication and supply management across all care settings. His experience in the medical device, pharmaceutical, and life sciences industries will be pivotal in advancing the company’s growth strategy towards achieving the vision of the Autonomous Pharmacy.
With over 25 years of experience in product development and regulatory compliance, Dr. Genova has a proven track record of delivering innovation and value in senior leadership roles. His focus on collaboration and trust among stakeholders will drive Omnicell’s mission to transform medication management across care settings.
Dr. Genova’s notable achievements include building an $800M division at Kos Pharmaceuticals and developing a reservoir insulin device. He holds multiple patents in medical and consumer technologies and has engineering degrees from the University of North Carolina.
Omnicell, founded in 1992, is committed to delivering outcomes-centric solutions through robotics, smart devices, software workflows, and analytics. These solutions help healthcare facilities worldwide achieve cost savings, improve efficiency, and move closer to the goal of the Autonomous Pharmacy.
For more information about Omnicell and its innovative solutions, visit omnicell.com. The company’s trademarks include OMNICELL and the Omnicell logo. For media inquiries or further information, contact Betsy Martinelli, Director of Corporate Marketing, at Betsy.Martinelli@omnicell.com or 412-334-3256.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
